Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573311 · ClinicalTrials.gov registry record · Phase 3
Actual Use Study of Tamsulosin in Men
A Phase 3 study of Urological Manifestations, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,117
- Enrollment target
- 20
- Study locations
NCT02573311 is a Phase 3 study of Urological Manifestations that has completed, run by Boehringer Ingelheim. The registered enrollment target is 1,117 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT02573311, a Phase 3 study of Urological Manifestations, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,117 participants
- Enrollment target
- 20
- Study locations
Study Summary
An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label instructions, also assess any reported adverse events during simulated OTC use.
Conditions Studied
Interventions
- DRUG tamsulosin hydrochloride
Study Locations (20)
Alabama
- Parkway Discount Drugs - Birmingham
- Homewood Pharmacy - Homewood
- Robert's Discount Pharmacy - Hoover
- Pharmacy at the Pig - McCalla
- Pinson Discount Drugs - Pinson
Minnesota
- Goodrich Pharmacy - Andover
- Goodrich Pharmacy - Blaine
- Goodrich Pharmacy - Elk River
- Northfield Pharmacy - Northfield
- Cub Pharmacy #1924 - Saint Louis Park
Georgia
- Sutton Family Pharmacy - Dalton
- Huff's Drug Store - Ellijay
- Wynn's Pharmacy Incorporated - Griffin
Florida
- Garden Drug - Fort Lauderdale
- Pill Box Pharmacy - Pembroke Pines
Missouri
- The Medicine Shoppe and Elsberry Pharmacy - Elsberry
- Albers' Specialty Pharmacy - Kansas City
Arizona
- ACACIA Apothecary and Wellness - Tucson
California
- Parkview Compounding Pharmacy - Rancho Cucamonga
Illinois
- Family Care Pharmacy - Highland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,117 participants |
| Start Date | 2015-09-23 |
| Est. Completion | 2016-08-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02573311
The ClinicalTrials.gov registry entry for NCT02573311 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urological Manifestations appearing as the primary indexed condition, and to 1 intervention - of which tamsulosin hydrochloride is the first listed.
NCT02573311 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Alabama, Minnesota, Georgia.
Frequently Asked Questions
What is clinical trial NCT02573311 about?
NCT02573311 is a clinical study titled "Actual Use Study of Tamsulosin in Men". An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following "stop use and ask a doctor if" and "ask a doctor before use" statements and if they take the medication according to the label i...
What is the current status of trial NCT02573311?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,117 participants. The study started on 2015-09-23. Estimated completion is 2016-08-01.
What conditions does trial NCT02573311 study?
This clinical trial studies the following conditions: Urological Manifestations.
What interventions are being tested in trial NCT02573311?
The interventions under investigation include: tamsulosin hydrochloride (DRUG).
Who is sponsoring clinical trial NCT02573311?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02573311 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urological Manifestations
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.